Answer
No. It is a monoclonal antibody that blocks RANKL. Both treatments reduce bone breakdown but work differently.
Sources for this answer
- Obodence 60 mg solution for injection in pre-filled syringeemc · SmPC Current selected SmPC · Version 3
- Osenvelt 120mg vialemc · SmPC Current selected SmPC · Version 3